Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$59,991,980
in 20 filings, $60.0M under 10b5-1 plans

Net −$59,991,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 82 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-09-17 Wang Xiaolin Sale −250 $30.02 $8K 12,195
2021-09-17 GOLDSMITH MARK A Director Sale −1,531 $30.02 $46K 46,472
2021-09-17 Horn Margaret A Sale −479 $30.02 $14K 25,999
2021-06-22 Miller Vincent A. Director Grant or award +3,617 23,750
2021-06-22 Miller Vincent A. Director Grant or award · Stock Option (Right to Buy) +12,659 12,659
2021-06-22 Exter Neil Director Grant or award +3,617 23,615
2021-06-22 Exter Neil Director Grant or award · Stock Option (Right to Buy) +12,659 12,659
2021-06-22 Borellini Flavia Director Grant or award +7,234 7,234
2021-06-22 Borellini Flavia Director Grant or award · Stock Option (Right to Buy) +25,318 25,318
2021-02-08 Schroeder Thilo Director Purchase +300,000 $45.00 $13.5M 300,000
2020-07-13 Schroeder Thilo Director Purchase +150,000 $26.00 $3.9M 2,668,214
2020-02-18 Schroeder Thilo Director Conversion +2,118,214 2,118,214
2020-02-18 Schroeder Thilo Director Purchase +400,000 $17.00 $6.8M 2,518,214
2020-02-18 Schroeder Thilo Director Conversion · Series B Preferred Stock −1,569,539 0
2020-02-18 Schroeder Thilo Director Conversion · Series C Preferred Stock −548,675 0

Page 39 of 39 · 775 trades